Skip to main content
. 2022 Mar 9;42(10):1888–1907. doi: 10.1523/JNEUROSCI.0998-21.2022

Figure 2.

Figure 2.

Major neuroimmunometabolic imbalances in neurodegenerative disorders. Several glucose, peptide, and lipid metabolic pathways are hindered in neurons and glia in these neurodegenerative diseases. These perturbations potentiate altered synthesis and transportation of different metabolites, leading to excitotoxicity, impaired phagocytosis, and inflammation in the CNS.